Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: PharMerica Corp.
Current Parent Company: KKR & Co.
Penalty: $100,000,000
Year: 2024
Date: July 3, 2024
Offense Group: government-contracting-related offenses
Primary Offense: False Claims Act and related
Secondary Offense: qui tam whistleblower lawsuit
Violation Description: In a qui tam whistleblower case in which there was no government intervention, PharMerica agreed to pay an amount reported to be over $100 million to resolve allegations the company won contracts for institutional pharmacy services by paying illegal kickbacks. The amount of the settlement was reported by the law firm representing the whistleblower.
Level of Government: federal
Action Type: private litigation
Court: District of New Jersey
Civil or Criminal Case: civil
Case ID: 1:11-cv-01326
Case Name: United States of America et al v. Omnicare, Inc. et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: New York
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: private equity (including portfolio companies)
Specific Industry of Current Parent: private equity (including portfolio companies)
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.